Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01420289 · ClinicalTrials.gov registry record · NA

Effect of HPIPC for the Treatment of Ischemic Ulcers in Subjects With PAD

A NA study of PVD and Arterial Ulcers, sponsored by Calvary Hospital, Bronx, NY.

Completed
Registry status
NA
Development phase
44
Enrollment target
1
Study location

NCT01420289 is a NA study of PVD and Arterial Ulcers that has completed, run by Calvary Hospital, Bronx, NY. The registered enrollment target is 44 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01420289, a NA study of PVD and Arterial Ulcers, has completed, sponsored by Calvary Hospital, Bronx, NY.

COMPLETED
Registry status
NA
Development phase
44 participants
Enrollment target
1
Study location

Study Summary

To evaluate the effects of HPIPC for the treatment of symptoms of PAD

Conditions Studied

Interventions

  • DEVICE High pressure intermittent pneumatic compression (HPIPC)
  • BEHAVIORAL Excercise

Study Locations (1)

New York

  • Center for Curative and Palliative wound Care, Calvary Hospital - The Bronx

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2009-01
Est. Completion 2011-06
Phase NA

Sponsor

Calvary Hospital, Bronx, NY

5 total trials

What the Registry Record Tells You About NCT01420289

The ClinicalTrials.gov registry entry for NCT01420289 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Calvary Hospital, Bronx, NY, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with PVD appearing as the primary indexed condition, and to 2 interventions - of which High pressure intermittent pneumatic compression (HPIPC) is the first listed.

NCT01420289 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT01420289 about?

NCT01420289 is a clinical study titled "Effect of HPIPC for the Treatment of Ischemic Ulcers in Subjects With PAD". To evaluate the effects of HPIPC for the treatment of symptoms of PAD

What is the current status of trial NCT01420289?

This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2009-01. Estimated completion is 2011-06.

What conditions does trial NCT01420289 study?

This clinical trial studies the following conditions: PVD, Arterial Ulcers.

What interventions are being tested in trial NCT01420289?

The interventions under investigation include: High pressure intermittent pneumatic compression (HPIPC) (DEVICE), Excercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT01420289?

This trial is sponsored by Calvary Hospital, Bronx, NY, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01420289 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.